Home/Filings/4/A/0001754429-25-000012
4/A//SEC Filing

Soderquist Ola 4/A

Accession 0001754429-25-000012

CIK 0001445815other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 1:12 PM ET

Size

8.2 KB

Accession

0001754429-25-000012

Insider Transaction Report

Form 4/AAmended
Period: 2024-10-25
Soderquist Ola
CFO10% Owner
Transactions
  • Other

    preferred

    2024-10-25$0.55/sh+10,069,396$5,487,82113,976,456 total
  • Other

    common

    2024-10-25$0.00/sh+500,000$500500,000 total
  • Other

    preferred

    2024-10-25$0.01/sh+100,000$50013,876,456 total
Footnotes (2)
  • [F1]The Shares were issued as payment for the sale of NDPD Pharma to Bioxytran
  • [F2]A 1:5 exchange of Preferred Stock (earlier issued under section 16b-3) into shares of Common Stock.

Issuer

BIOXYTRAN, INC

CIK 0001445815

Entity typeother

Related Parties

1
  • filerCIK 0001754429

Filing Metadata

Form type
4/A
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 1:12 PM ET
Size
8.2 KB